Healthcare provider profile · identity verified

Mosab Abdulbaset Frefer, MD

Internal Medicine · TUCSON, AZ · NPI 1659800977

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	134
Gabapentin	Gabapentin	365	102
Levothyroxine Sodium	Levothyroxine Sodium	355	94
Amlodipine Besylate	Amlodipine Besylate	307	98
Furosemide	Furosemide	263	69
Eliquis	Apixaban	246	50
Trazodone Hcl	Trazodone Hcl	219	74
Lisinopril	Lisinopril	218	68
Metformin Hcl	Metformin Hcl	162	41
Oxycodone Hcl	Oxycodone Hcl	154	36
Potassium Chloride	Potassium Chloride	143	44
Tamsulosin Hcl	Tamsulosin Hcl	133	52
Omeprazole	Omeprazole	128	57
Losartan Potassium	Losartan Potassium	125	53
Tramadol Hcl	Tramadol Hcl	123	35
Pantoprazole Sodium	Pantoprazole Sodium	122	46
Famotidine	Famotidine	119	55
Metoprolol Tartrate	Metoprolol Tartrate	111	38
Sertraline Hcl	Sertraline Hcl	105	32
Baclofen	Baclofen	104	22
Mirtazapine	Mirtazapine	104	35
Escitalopram Oxalate	Escitalopram Oxalate	95	32
Duloxetine Hcl	Duloxetine Hcl	93	28
Ondansetron Hcl	Ondansetron Hcl	89	44
Quetiapine Fumarate	Quetiapine Fumarate	86	27
Albuterol Sulfate Hfa	Albuterol Sulfate	81	41
Lorazepam	Lorazepam	79	21
Levetiracetam	Levetiracetam	78	19
Methocarbamol	Methocarbamol	78	41
Buspirone Hcl	Buspirone Hcl	77	20
Carvedilol	Carvedilol	77	37
Hydralazine Hcl	Hydralazine Hcl	73	27
Divalproex Sodium	Divalproex Sodium	72	15
Metoprolol Succinate	Metoprolol Succinate	72	33
Clopidogrel	Clopidogrel Bisulfate	71	28
Hydroxyzine Hcl	Hydroxyzine Hcl	70	36
Azithromycin	Azithromycin	68	41
Donepezil Hcl	Donepezil Hcl	68	17
Midodrine Hcl	Midodrine Hcl	68	23
Clonazepam	Clonazepam	65	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	17
Finasteride	Finasteride	64	15
Montelukast Sodium	Montelukast Sodium	63	22
Xarelto	Rivaroxaban	63	11
Alendronate Sodium	Alendronate Sodium	62	13
Rosuvastatin Calcium	Rosuvastatin Calcium	58	22
Allopurinol	Allopurinol	56	20
Glipizide	Glipizide	55	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	14
Fluticasone Propionate	Fluticasone Propionate	51	26
Citalopram Hbr	Citalopram Hydrobromide	50	20
Propranolol Hcl	Propranolol Hcl	50	suppressed
Simvastatin	Simvastatin	47	14
Warfarin Sodium	Warfarin Sodium	45	suppressed
Bupropion Xl	Bupropion Hcl	44	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	19
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	42	12
Acetic Acid	Acetic Acid	41	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	41	12
Myrbetriq	Mirabegron	39	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	suppressed
Risperidone	Risperidone	38	suppressed
Cephalexin	Cephalexin	37	28
Clonidine Hcl	Clonidine Hcl	37	12
Lactulose	Lactulose	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Pregabalin	Pregabalin	36	11
Insulin Lispro	Insulin Lispro	35	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	23
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	12
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	28	12
Latanoprost	Latanoprost	28	suppressed
Spironolactone	Spironolactone	28	15
Doxycycline Hyclate	Doxycycline Hyclate	27	17
Atenolol	Atenolol	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	17
Buprenorphine Hcl	Buprenorphine Hcl	23	suppressed
Jardiance	Empagliflozin	23	11
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Primidone	Primidone	22	suppressed
Rexulti	Brexpiprazole	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Methylprednisolone	Methylprednisolone	21	16
Nystatin	Nystatin	21	14
Farxiga	Dapagliflozin Propanediol	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	11
Prednisone	Prednisone	20	13
Synthroid	Levothyroxine Sodium	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Mirabegron Er	Mirabegron	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Invega Sustenna	Paliperidone Palmitate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Levofloxacin	Levofloxacin	15	12
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Zaleplon	Zaleplon	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Perphenazine	Perphenazine	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lactated Ringers	Ringer's Solution,lactated	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error